The Multilex drug knowledge base is widely used throughout the UK and is integrated into clinical systems across the whole healthcare community. The Multilex drug terminology holds clinical and commercial information on more than 75,000 pharmaceutical products and packs and provides active clinical decision support and referential medicines information for all healthcare professionals.

For more information please visit http://www.fdbhealth.co.uk/.

Overview

First DataBank (FDB) were in the first wave of suppliers to recognize the potential of SNOMED CT and begin to integrate support for SNOMED CT into their existing clinical decision support solutions. Their primary use of SNOMED CT in the patient's electronic health record (EHR) is to detect safety issues arising from certain combinations of medications, diagnoses and drug adverse reaction histories. In 2006 FDB introduced support for products and packs encoded using the NHS SNOMED CT UK Drug Extension. In the following year FDB launched new modules within the Multilex drug knowledge base supporting Drug-Condition Checking and Drug Sensitivity (Allergy) checking for the SNOMED CT EHR. 

System vendors implementing Multilex decision support within SNOMED CT-enabled medical record applications include CSC (Lorenzo system), EPIC and JAC in secondary care, and CSE Servelec (RiO system) in community/mental health. Currently only pre-coordinated expressions are supported by the live Multilex SNOMED CT based decision support solutions.

Drug-Condition Contraindication Checks

The contraindications module alerts the clinician when a medication proposed to treat a disorder is incompatible with another of the patient's disorders or clinical states. For example a beta blocker like propranolol might be prescribed to treat someone with high blood pressure. However if that patient also has asthma, their asthma might significantly worsen or a dangerous acute attack might be produced by the drug.

Thousands of such drug-condition contraindications exist and nearly all medications have at least one. Without point of care decision support, the clinician must rely on memory or search reference sources for each drug prescribed. Also there is a risk that a contraindicating condition may be in the record but unknown to the prescribing clinician.

In a SNOMED CT enabled EHR, both the drugs (e.g.

Internally FDB maintain their own local ontology representing only those conditions relevant to prescribing decision support (e.g. asthma, gastric ulcer, heart disease, pregnancy). The items in this ontology are linked to SNOMED CT codes as required to support this (contraindication checking) use case. These SNOMED CT links range from the obvious, such as linking

FDB reviews the relevant SNOMED CT domains (i.e.

Drug Sensitivity (Allergy) Checks

The sensitivities module alerts the clinician when a proposed drug for a patient is either stated in that patient's record to have caused a previous adverse reaction or when an adverse reaction has occurred to a similar drug and thus likely to elicit a similar adverse response. For example, a patient allergic to penicillin is likely to react to most other drugs containing a β-lactam ring in their molecular structures.

In a similar way to how FDB links SNOMED CT conditions to its own internal ontology, SNOMED CT concepts which suggest allergy or previous adverse reactions to a medication are also linked to an internal FDB ontology for representing medication ingredients. This ontology is designed specifically to support allergic and adverse reaction cross-reactivity.